- Platelet PGD® Test Cited as Important Safety Measure
- AABB hosts conference on secondary testing for bacterial contamination in platelets
- Congress directs FDA to report on bacterial contamination of platelets in appropriations bill
- FDA clears Verax platelet PGD tests as "safety measure" for platelet transfusions
- FDA clears PGD as the first rapid test for bacteria in pooled platelets
- Verax to Present Whole Blood Derived Platelet testing data at AABB annual meeting in New Orleans
- Verax Biomedical enters exclusive worldwide distribution agreement with Fenwal Incorporated
- Verax Biomedical Platelet PGD® Test for Bacterial Detection Now CE Marked
Verax Biomedical
Skip to contentVerax Biomedical is the leading developer of rapid tests for the detection of bacterial contaminants in blood components, tissues for transplantation and cellular therapies. These tests are based upon our proprietary Pan Genera® Detection (PGD®) technology which permits the rapid detection of a broad array of bacteria in a simple, easy to use test format.
